ISA Pharmaceuticals
Pieter van der Meijden (MSc) is a member of the management team of “De Hoge Dennen” Holding B.V., a family-owned investment company. At De Hoge Dennen, he is responsible for developing strategy and implementation. He also is responsible for fund investments and the coordination of operational activities. Prior to joining De Hoge Dennen, he worked as managing partner at the investment company Berk Partners (2003-2007), as Managing Director Dutch Brand at Halder Invest (later called GIMV Nederland), and as Deputy Director at NIBC. Mr. Van der Meijden studied Business Economics at Erasmus University in Rotterdam.
This person is not in the org chart
This person is not in any offices
ISA Pharmaceuticals
ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology.